Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
-
Published in Advance
August 29, 2019,
doi:
10.1101/gr.246900.118
Genome Res.
September 2019
vol. 29
no. 9
1442-1452